- 专利标题： EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES
-
申请号： EP18197990.7申请日： 2013-11-21
-
公开(公告)号： EP3485901A1公开(公告)日： 2019-05-22
- 发明人: ANDERSON, Mark , ATTAR, Ricardo , DIEM, Michael , HYUN, Linus , JACOBS, Steven , KING, Alastair , KLEIN, Donna , MOORES, Sheri , O'NEIL, Karyn , PICHA, Kristen
- 申请人： Janssen Biotech, Inc.
- 申请人地址： 800/850 Ridgeview Drive Horsham, PA 19044 US
- 专利权人： Janssen Biotech, Inc.
- 当前专利权人： Janssen Biotech, Inc.
- 当前专利权人地址： 800/850 Ridgeview Drive Horsham, PA 19044 US
- 代理机构： Goodfellow, Hugh Robin
- 优先权： US201261728906P 20121121; US201261728914P 20121121; US201261728912P 20121121; US201361782550P 20130314; US201361809541P 20130408
- 主分类号： A61K38/39
- IPC分类号： A61K38/39 ; A61K38/00 ; C07K14/78 ; A61P35/00 ; A61K39/395 ; C07K16/28 ; A61K45/06
摘要：
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.
公开/授权文献
- EP3485901B1 EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES 公开/授权日：2021-10-13
信息查询
IPC分类:
